• Lenabasum Fails to Show Efficacy in Diffuse Cutaneous SSc, Phase 3 Trial Shows
  • Same But Different Photo Contest Celebrates People With Rare Diseases
  • Phase 2 Trial of CellCept Plus Esbriet for SSc-ILD Enrolling in US
  • Xperiome Platform Aims to Streamline Searches for Rare Diseases, Gain Patient Input
  • Scleroderma Patients Lacking Hallmark Autoantibodies Form Distinct Subset, Study Says
  • EveryLife Foundation Launches Scholarship Fund for Rare Disease Community in US
  • Infections Needing Hospital Stay Costly for Scleroderma Patients in US
  • New Streaming Channel Showcases Rare Disease Films
  • FLI1 Gene Variant Linked to Increased Scleroderma Risk, Greater Skin Thickness in Study
  • 1st Patients Dosed, Enrollment Open in Phase 2a Trial of CBD Therapy EHP-101 for dcSSc
  • Cell Therapy FCR001 to Enter Phase 1/2a Trial for Diffuse Cutaneous SSc
  • Sleep Apnea Linked to High Blood Pressure in Lungs of Adults With Scleroderma